FIELD: medicine, phthisiology.
SUBSTANCE: method involves both administration of antituberculosis preparations and using cortexin in the dose 10 mg in physiological solution. Cortexin is administrated by intramuscular route, 10 injections for treatment course. Method provides enhancing effectiveness and reducing treatment period. Invention can be used in treatment of adverse neurotoxic responses caused by effect of antituberculosis preparations.
EFFECT: improved method of treatment.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUBECULOUS-CAUSED MEDICAMENTOUS POLYNEUROPATHY APPROACH | 2007 |
|
RU2353360C2 |
| METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
| METHOD FOR MODELING DRUG NEUROTOXICITY USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2795524C1 |
| METHOD FOR PREVENTION OF COMPLICATIONS INDUCED BY ISONIAZID | 2015 |
|
RU2597788C1 |
| METHOD FOR EXPERIMENTAL CORRECTION OF NEUROTOXIC ACTION OF DAPSONE | 2013 |
|
RU2525180C1 |
| METHOD OF REDUCING INTOLERANCE TO ANTITUBERCULOUS PREPARATIONS | 2009 |
|
RU2412701C2 |
| METHOD OF CORRECTION OF PSYCHOVEGETATIVE DYSFUNCTIONS AND PROPHYLAXIS OF NEURO- AND CARDIOTOXIC RESPONSES TO POLYCHEMICAL THERAPY IN PATIENTS WITH TUBERCULOSIS | 2007 |
|
RU2354371C1 |
| METHOD FOR REDUCING ISONIAZID NEUROTOXICITY EXPERIMENTALLY | 2014 |
|
RU2574027C1 |
| METHOD OF TREATMENT OF PULMONARY TUBERCULOSIS | 2006 |
|
RU2340372C2 |
| WAY OF PREVENTION OF COLLATERAL NEURO - CARDIO - AND HEPATOTOXIC REACTIONS TO ANTITUBERCULOUS PREPARATIONS | 2007 |
|
RU2362558C1 |
